Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Bisphenol A (BPA) Linked To Obesity, Diabetes: Studies February 21, 2012 Staff Writers Add Your Comments The ubiquitous chemical additive bisphenol-A (BPA), which is used in plastic bottles and can liners, may be contributing to the obesity epidemic in the United States and throughout the developed world, according to the findings of two new studies. According to a study published in the Journal of Clinical Endocrinology & Metabolism, Chinese researchers found that individuals with the highest levels of BPA in their urine were also the most obese. In another study published in the medical journal PLoS ONE, Spanish researchers report that BPA may trigger the release of high levels of insulin, which is used to break down food and can cause the body to stop responding to the insulin releases. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Because BPA is what is known as an endocrine disruptor, it can confuse the body’s hormones. In fact, it was originally designed as a form of synthetic estrogen before it was remarketed as a plastic liner that could preserve food. Researchers say that two things might be happening. First, BPA could be telling fat cells to take in more fat than they usually would. Second, it could be telling the body to double the release of insulin when someone eats. The excessive insulin, which tells the body to break down food, will eventually start being ignored by the body as it gets desensitized, meaning that food turns to fat instead of being broken down properly. The Chinese researchers looked at nearly 3,400 adults ages 40 and older. They found that the 25% who tested highest for BPA urine levels were 50% more likely to be obese than those with lower levels of the chemical. That study also found signs of insulin resistance. The Spanish researchers looked at mice and pancreatic cell functions when exposed to high levels of BPA, finding that BPA doubled insulin release and can lead to metabolic disorders in humans, including Type 2 diabetes, heart disease and insulin resistance. The mice used in the study were given modified human cells, leading the researchers to determine that BPA can no longer be considered a “weak” estrogen because of its potency. BPA is used to make many plastic products hard and shatterproof. It is used in the manufacture of many consumer products, such as bottles, cups, can liners, baby products and other food containers. Exposure to BPA has long been suspected of causing hormonal changes by impacting the human endocrine system. Some prior research has also suggested that BPA side effects can cause developmental abnormalities and other problems over time in infants and young children. Tags: Bisphenol A, BPA, Chemical, Diabetes, Heart Disease, Stroke More Lawsuit Stories Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 January 15, 2026 Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026 $79 Billion in Class Action Settlements Paid by Corporations in 2025: Report January 15, 2026 0 Comments URLThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025) Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025) Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)
Abbott FreeStyle Libre Lawsuit Alleges Recalled Glucose Monitor Led to Inaccurate Readings January 15, 2026
Bard PowerPort Infection Lawsuit Set for Trial To Begin April 21, 2026 (Posted: today) A federal judge has scheduled a series of Bard PowerPort trials between April 2026 and February 2027, which will focus on allegations that defective design flaws made the devices susceptible to infections, fractures and migration. MORE ABOUT: BARD POWERPORT LAWSUITCook Flexor Sheath Lawsuit Claims Defective Catheter Device Led to Woman’s Death (01/06/2026)More Than 2,500 Bard Powerport Lawsuits Filed in Federal Courts Nationwide (12/05/2025)Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 (11/26/2025)
Depo-Provera Lawyers Intending To Remain in MDL Leadership Must Seek Reappointment: Judge (Posted: yesterday) A federal judge is calling for dozens of attorneys to reapply for leadership positions in Depo-Provera brain tumor litigation before their appointments expire in March. MORE ABOUT: DEPO-PROVERA LAWSUITSide Effects From Depo-Provera Shots Led to Brain Tumor, Multiple Surgeries: Lawsuit (01/06/2026)Top Medical Device Recalls and Warnings of 2025 Resulting in Lawsuits and Investigations (12/29/2025)Depo-Provera Brain Tumor Lawsuit To Be Prepared for Trial by December 2026 (12/23/2025)
Judge Overseeing Ozempic Blindness Lawsuits Meeting With Lawyers for Initial Conference (Posted: 2 days ago) Parties involved with Ozempic blindness lawsuits will meet with a federal judge overseeing the litigation for the first time on January 13. MORE ABOUT: OZEMPIC LAWSUITFDA To Remove Suicide Risks From GLP-1 Side Effects Warnings (01/15/2026)Link Between Gastroparesis and Ozempic, Other GLP-1 Medications To Be Reviewed by MDL Court in 2026 (12/23/2025)Ozempic, Wegovy Vision Loss Lawsuits Sent to Stomach Injury Judge, as Separate MDL (12/18/2025)